Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality therapy at home shows promise for MS hand problems

NCT ID NCT05713890

Symptom relief Sponsor: IRCCS San Raffaele Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a home-based virtual reality program can help people with multiple sclerosis improve hand function. 60 participants will either watch and imitate hand tasks in VR or watch landscapes before doing the same tasks. The program lasts 3 weeks with daily sessions. Researchers will measure hand dexterity, grip strength, and brain changes using MRI.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Home-based virtual reality action observation treatment
What this could lead to
If it works, this could offer a convenient, home-based therapy to improve hand dexterity and strength in people with multiple sclerosis.
What could go wrong
This is a small, early-stage study (60 people) comparing two similar VR approaches. The improvement may be small or not last long, and results may not apply to everyone with MS.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2023

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-65 years; * Diagnosis of MS according to 2017 revised McDonald criteria; * Ability to understand the purpose and risks of the study and provide signed informed consent; * Ability to remotely perform VR-AOT; * Right pre-morbid handedness (EHI\>50); * Muscle strength deficit involving the right upper limb (≥1 point decrease of MRC scale); * Presence of activity limitation of the right hand (need of adaptations, supervision or help by another person for the execution of daily living activities according to items 1-6 of the FIM); * EDSS score 2.0-7.0 (inclusive); * Cerebellar functional system score of the EDSS ≤1; * Baseline 9HPT score \>21 seconds and \<180 seconds. Exclusion Criteria: * MRI contraindications; * Significant visual deficits not allowing to observe VR stimuli; * Moderate to severe pain disturbances (VAS≥4); * Concomitant neuro-psychiatric or systemic diseases (other than MS); * Clinical relapses or steroid treatment in the past 3 months; * Modification of symptomatic treatment or botulin toxin injection in the upper limb in the past 3 months; * Stable disease-modifying treatment for MS for ≤6 months; * Rehabilitation treatment in the past 3 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Multiple sclerosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Multiple sclerosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • IRCCS San Raffaele

    RECRUITING

    Milan, Milan, 20132, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.